FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023360711> ?p ?o ?g. }

• W2023360711 endingPage "2939" @default.
• W2023360711 startingPage "2931" @default.
• W2023360711 abstract "When second-generation antipsychotics (SGAs), also called atypical antipsychotics, were introduced in the 1990s, early research suggested that these drugs offered better tolerability and adherence than first-generation antipsychotics (FGAs), or typical antipsychotics. This presumably would reduce the need for hospital services. However, health research to test this hypothesis has focused mostly on psychiatric readmissions.The objective of this study was to compare rates of all-cause hospitalization among patients receiving different classes of antipsychotics (SGAs, FGAs, both, or neither) in a large, all-ages sample of both institutionalized and noninstitutionalized Medicare beneficiaries.We examined the 2005 Medicare Current Beneficiary Survey Cost and Use file for 11,236 survey participants. Antipsychotic utilization was characterized in terms of class: FGA (ie, chlorpromazine, fluphenazine, haloperidol, loxapine, perphenazine, thiothixene, thioridazine, or trifluoperazine) or SGA (ie, aripiprazole, clozapine, olanzapine, quetiapine, risperidone, or ziprasidone). Hospitalization was defined in terms of whether a Medicare beneficiary was admitted to the hospital for any reason in 2005, and was measured in terms of the number of hospital visits. In our final model, we included the following confounding variables: disability status (> or =1 limitation in activities of daily living), Rosow-Breslau impairment score (difficulty with walking, stooping, crouching, kneeling, or doing heavy housework), cognitive impairment (diagnosis of Alzheimer's disease or memory loss that interfered with daily activity), and health behavior variables (body mass index and smoking status).A total of 3.5% of Medicare beneficiaries (1.3 million) filled > or =1 prescription for an antipsychotic medication in 2005. Controlling for demographic, socioeconomic, health, and disability variables, SGA-only users were more than twice as likely (odds ratio [OR] = 2.2 [95% CI, 1.7-2.9]) and combination users were more than 6 times as likely (OR = 6.3 [95% CI, 2.4-16.2]) as nonusers to be hospitalized. The odds of FGA users being hospitalized were not significantly different from nonusers (OR = 1.4 [95% CI, 0.7-2.8]).This analysis yielded provocative, but by no means conclusive, evidence that SGAs as a class are not necessarily superior to FGAs in mitigating patient's use of hospital services under real-world conditions. Systematic analysis of this relationship with a large, multiple-year sample of Medicare beneficiaries is warranted." @default.
• W2023360711 created "2016-06-24" @default.
• W2023360711 creator A5003610736 @default.
• W2023360711 creator A5014913295 @default.
• W2023360711 creator A5026568748 @default.
• W2023360711 creator A5035199369 @default.
• W2023360711 creator A5053591772 @default.
• W2023360711 creator A5058792065 @default.
• W2023360711 creator A5079781082 @default.
• W2023360711 date "2009-12-01" @default.
• W2023360711 modified "2023-09-26" @default.
• W2023360711 title "The association between class of antipsychotic and rates of hospitalization: Results of a retrospective analysis of data from the 2005 medicare current beneficiary survey" @default.
• W2023360711 cites W1859825375 @default.
• W2023360711 cites W1968103155 @default.
• W2023360711 cites W1974441939 @default.
• W2023360711 cites W1974491760 @default.
• W2023360711 cites W1976642152 @default.
• W2023360711 cites W1993729360 @default.
• W2023360711 cites W1996333016 @default.
• W2023360711 cites W2038563027 @default.
• W2023360711 cites W2042267709 @default.
• W2023360711 cites W2043296995 @default.
• W2023360711 cites W2051499477 @default.
• W2023360711 cites W2057145321 @default.
• W2023360711 cites W2060417841 @default.
• W2023360711 cites W2064551384 @default.
• W2023360711 cites W2067227255 @default.
• W2023360711 cites W2074732316 @default.
• W2023360711 cites W2075794937 @default.
• W2023360711 cites W2102750847 @default.
• W2023360711 cites W2104441755 @default.
• W2023360711 cites W2124552233 @default.
• W2023360711 cites W2131614010 @default.
• W2023360711 cites W2140468511 @default.
• W2023360711 cites W2143189599 @default.
• W2023360711 cites W2144888171 @default.
• W2023360711 cites W2146966503 @default.
• W2023360711 cites W2152770536 @default.
• W2023360711 cites W2159155203 @default.
• W2023360711 cites W2164160691 @default.
• W2023360711 cites W2171956687 @default.
• W2023360711 cites W2405736558 @default.
• W2023360711 cites W4235517461 @default.
• W2023360711 cites W4244985387 @default.
• W2023360711 cites W4252414095 @default.
• W2023360711 doi "https://doi.org/10.1016/j.clinthera.2009.12.017" @default.
• W2023360711 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20110033" @default.
• W2023360711 hasPublicationYear "2009" @default.
• W2023360711 type Work @default.
• W2023360711 sameAs 2023360711 @default.
• W2023360711 citedByCount "14" @default.
• W2023360711 countsByYear W20233607112012 @default.
• W2023360711 countsByYear W20233607112014 @default.
• W2023360711 countsByYear W20233607112015 @default.
• W2023360711 countsByYear W20233607112016 @default.
• W2023360711 countsByYear W20233607112017 @default.
• W2023360711 countsByYear W20233607112020 @default.
• W2023360711 crossrefType "journal-article" @default.
• W2023360711 hasAuthorship W2023360711A5003610736 @default.
• W2023360711 hasAuthorship W2023360711A5014913295 @default.
• W2023360711 hasAuthorship W2023360711A5026568748 @default.
• W2023360711 hasAuthorship W2023360711A5035199369 @default.
• W2023360711 hasAuthorship W2023360711A5053591772 @default.
• W2023360711 hasAuthorship W2023360711A5058792065 @default.
• W2023360711 hasAuthorship W2023360711A5079781082 @default.
• W2023360711 hasConcept C118552586 @default.
• W2023360711 hasConcept C126322002 @default.
• W2023360711 hasConcept C160735492 @default.
• W2023360711 hasConcept C162324750 @default.
• W2023360711 hasConcept C2776412080 @default.
• W2023360711 hasConcept C2776534028 @default.
• W2023360711 hasConcept C2776619155 @default.
• W2023360711 hasConcept C2776978879 @default.
• W2023360711 hasConcept C2777270317 @default.
• W2023360711 hasConcept C2780057945 @default.
• W2023360711 hasConcept C2780211496 @default.
• W2023360711 hasConcept C2780494398 @default.
• W2023360711 hasConcept C2780634440 @default.
• W2023360711 hasConcept C2780864610 @default.
• W2023360711 hasConcept C2780948584 @default.
• W2023360711 hasConcept C50522688 @default.
• W2023360711 hasConcept C513476851 @default.
• W2023360711 hasConcept C71924100 @default.
• W2023360711 hasConceptScore W2023360711C118552586 @default.
• W2023360711 hasConceptScore W2023360711C126322002 @default.
• W2023360711 hasConceptScore W2023360711C160735492 @default.
• W2023360711 hasConceptScore W2023360711C162324750 @default.
• W2023360711 hasConceptScore W2023360711C2776412080 @default.
• W2023360711 hasConceptScore W2023360711C2776534028 @default.
• W2023360711 hasConceptScore W2023360711C2776619155 @default.
• W2023360711 hasConceptScore W2023360711C2776978879 @default.
• W2023360711 hasConceptScore W2023360711C2777270317 @default.
• W2023360711 hasConceptScore W2023360711C2780057945 @default.
• W2023360711 hasConceptScore W2023360711C2780211496 @default.
• W2023360711 hasConceptScore W2023360711C2780494398 @default.
• W2023360711 hasConceptScore W2023360711C2780634440 @default.
• W2023360711 hasConceptScore W2023360711C2780864610 @default.
• W2023360711 hasConceptScore W2023360711C2780948584 @default.

• next